Collaborations & Alliances

Bioaster, Janssen & Cancer Center of Lyon Team Up

Form hepatitis B collaboration to bring a predictive model for the development of novel therapies

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bioaster, and the Cancer Center of Lyon (CRCL) have signed a contract with Janssen-Cilag SAS, one of the Janssen Pharmaceutical Companies of Johnson & Johnson to advance the global fight against chronic hepatitis B virus (HBV). The collaboration is jointly coordinated by Janssen France and Johnson & Johnson Innovation. Hepatitis B is a potentially life-threatening liver infection caused by HBV. There are today an estimated number of 240 million people worldwide that carry the virus an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters